Healthcare provider profile · identity verified

Samer Shaja, DO

Family Practice · SOUTHFIELD, MI · NPI 1760831648

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	181
Amlodipine Besylate	Amlodipine Besylate	433	161
Rosuvastatin Calcium	Rosuvastatin Calcium	343	135
Losartan Potassium	Losartan Potassium	263	99
Albuterol Sulfate Hfa	Albuterol Sulfate	224	89
Metformin Hcl	Metformin Hcl	213	89
Lisinopril	Lisinopril	194	81
Hydrochlorothiazide	Hydrochlorothiazide	184	62
Metoprolol Succinate	Metoprolol Succinate	163	67
Furosemide	Furosemide	147	55
Gabapentin	Gabapentin	145	67
Levothyroxine Sodium	Levothyroxine Sodium	144	45
Carvedilol	Carvedilol	134	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	29
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	124	49
Potassium Chloride	Potassium Chloride	123	38
Pantoprazole Sodium	Pantoprazole Sodium	122	45
Fluticasone Propionate	Fluticasone Propionate	117	59
Tamsulosin Hcl	Tamsulosin Hcl	117	47
Metformin Hcl Er	Metformin Hcl	116	45
Alendronate Sodium	Alendronate Sodium	114	39
Diclofenac Sodium	Diclofenac Sodium	111	67
Glipizide	Glipizide	97	39
Omeprazole	Omeprazole	90	48
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	88	24
Tramadol Hcl	Tramadol Hcl	86	38
Nifedipine Er	Nifedipine	80	30
Clopidogrel	Clopidogrel Bisulfate	77	27
Triamcinolone Acetonide	Triamcinolone Acetonide	77	58
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	72	33
Naproxen	Naproxen	72	34
Metoprolol Tartrate	Metoprolol Tartrate	71	33
Warfarin Sodium	Warfarin Sodium	71	22
Jardiance	Empagliflozin	69	26
Montelukast Sodium	Montelukast Sodium	69	25
Duloxetine Hcl	Duloxetine Hcl	64	35
Famotidine	Famotidine	63	25
Hydralazine Hcl	Hydralazine Hcl	61	17
Ozempic	Semaglutide	61	11
Allopurinol	Allopurinol	57	22
Spironolactone	Spironolactone	56	23
Ibuprofen	Ibuprofen	54	32
Eliquis	Apixaban	51	26
Simvastatin	Simvastatin	51	20
Sildenafil Citrate	Sildenafil Citrate	50	16
Finasteride	Finasteride	49	23
Donepezil Hcl	Donepezil Hcl	48	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	17
Tizanidine Hcl	Tizanidine Hcl	43	28
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	42	19
Prednisone	Prednisone	41	28
Pravastatin Sodium	Pravastatin Sodium	39	13
Lactulose	Lactulose	36	15
Sertraline Hcl	Sertraline Hcl	36	18
Glipizide Er	Glipizide	35	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	33	17
Dropsafe Prep Pads	Alcohol Antiseptic Pads	32	13
Atenolol	Atenolol	31	12
Zolpidem Tartrate	Zolpidem Tartrate	31	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Ezetimibe	Ezetimibe	28	14
Pioglitazone Hcl	Pioglitazone Hcl	28	12
Enalapril Maleate	Enalapril Maleate	27	suppressed
Levetiracetam	Levetiracetam	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	13
Oxybutynin Chloride Er	Oxybutynin Chloride	25	11
Latanoprost	Latanoprost	24	13
Mirtazapine	Mirtazapine	24	13
Alprazolam	Alprazolam	23	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Methotrexate	Methotrexate Sodium	22	11
Bupropion Xl	Bupropion Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Valsartan	Valsartan	20	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	19	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Torsemide	Torsemide	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Timolol Maleate	Timolol Maleate	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Colchicine	Colchicine	14	suppressed
Risperidone	Risperidone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Glimepiride	Glimepiride	13	suppressed
Invega Sustenna	Paliperidone Palmitate	13	suppressed
Linzess	Linaclotide	13	suppressed
Novolin R Flexpen	Insulin Regular, Human	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Topiramate	Topiramate	13	suppressed
Trazodone Hcl	Trazodone Hcl	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Varenicline Tartrate	Varenicline Tartrate	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Novolin N	Insulin Nph Human Isophane	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error